Small Cap Voice

GrowLife, Inc. Reports Over $4.4m in Revenue in First Six Months of 2019 Compared to $4.6m in Revenue for ALL of 2018

Summary

* GrowLife reports gross revenue of $2.2 million as compared to revenue of $1.2 million for the same period in 2018, an increase of 82%

* GrowLife reports gross profit for the six-month period ending on June 30, 2019 of $1.4 million, compared to $187,900 in the same period last year, representing a 669% increase

* GrowLife focused product profitability in Q2 of 2019, which resulted in gross margin increases to over 30% from 9% for the same period last year, an increase of 232%

* GrowLife continues to experience growth due to the successful integration of recently acquired EZ-CLONE Enterprises, Inc. and increased demand for cloning products for use in hemp CBD products.

KIRKLAND, Wash. , Aug. 12, 2019 (GLOBE NEWSWIRE) — GrowLife, Inc. (OTC: PHOT) (“GrowLife” or the “Company”), one of the nation’s most recognized indoor cultivation product and service providers, today announced financial results for the period ending June 30, 2019, and provided an overview of recent operational highlights from that quarter and the first half of 2019. The company experienced surging growth over last year, showing an 82% increase in revenue over Q2 2018, from $1.2 million to over $2.2 million in Q2 2019. Additionally, the company continued to make significant progress towards profitability, reporting $1.4m in gross profit for the six month period ending June 30, 2019, a 669% increase over the same period last year. This was due to a major shift in profit margins, which increased to 31% in Q2 2019 compared to just 9% in Q2 2019.

“Beyond almost triple-digit revenue growth and almost surpassing last year’s revenue in just the first half of this year, I could not be more proud of the team’s performance that led to an increase in our gross profit of over 600% year-over-year,” said GrowLife CEO Marco Hegyi. “As we continue to shift from a   commodity business to a full-scale manufacturer of the industry’s leading cloning solution, our margins continue to increase and we continue to focus on profitability. As the cannabis industry, and more specifically the hemp-CBD market continues to experience explosive growth across the globe, GrowLife is extremely well-positioned to take advantage of this market opportunity through our innovative cloning product offering. This is illustrated in the fact that our revenue for the first six months of this year represents nearly all revenue generated in 2018.”

“As we look to bring further innovation in cultivation technologies, we utilized this quarter to continue to invest and build out manufacturing capacity in order to meet our increasing backlog of orders as well as the further growing demand for the EZ-CLONE product line. We are extremely confident that through our strategic investment in EZ CLONE, we have positioned ourselves very well to capitalize on these expanding market opportunities. Where EZ CLONE was able to create a quality product with steady growth, GrowLife has propelled it into an international brand being utilized by some of the largest grow operations in the world.”

SECOND QUARTER 2019 FINANCIAL RESULTS

Net Revenue: For the period ending June 30, 2019, GrowLife showed net revenue of $2.2 million as compared to revenue of $1.2 million for the period that ended June 30, 2018, an increase of 82%.

Gross Profit: For the period ending June 30, 2019, GrowLife showed gross profit of $675,773 as compared to revenue of $111,481 for the period that ended June 30, 2018, an increase of 506%.

Gross Profit Margin: Gross Profit Margin, expressed as a percentage of the difference between revenue and cost of goods sold divide...

Revenue increased 19% versus the second quarter in 2018; up 40% from first quarter 2019

IRVINE, CA / ACCESSWIRE / August 8, 2019 / Terra Tech Corp. (OTCQX:TRTC) (“Terra Tech” or the “Company”), a vertically integrated cannabis-focused agriculture company, today announced its financial results for the period ended June 30, 2019.

Derek Peterson, Chief Executive Officer of Terra Tech, commented, “We generated $10.37 million in revenue during the second quarter of 2019, a 19% increase from the $8.72 million in the same period of 2018. Gross margins saw a 526-basis point improvement over the prior year’s quarter due to our lower cost of goods and higher margin private label sales. These strong results were driven by one of our healthiest quarters on the retail level, especially in our San Leandro dispensary which commenced adult use sales in May, further positioning us as a leading vendor in California.

“The Company is as lean and healthy as it has ever been, and future quarterly results are expected to reflect the strength of our retail position and streamlined operations. In addition to our San Leandro performance, this quarter has seen several other milestones, including the launch of Terra Tech’s cannabis delivery service in Santa Ana which has cemented us as a major supplier of medical and adult-use cannabis to Santa Ana and its surrounding cities. The Company has made substantial headway in Nevada as well, where we started the process of opening our Blüm CBD store located in a highly trafficked section of Downtown Las Vegas. In Reno, we acquired complete ownership of our Blüm Reno dispensary allowing us to ramp cultivation and production.

“Our quarterly performance shows that the Company is trending in the right direction. Our restructuring program is well underway and we have already begun transitioning out of our non-core assets, streamlined both our operations and headcount, and identified some potential acquisition targets. Terra Tech is also looking to leverage relationships to investigate operations in the global CBD market due to its wide appeal, opposed to the heavily regulated cannabis market which is yet to see the same level of acceptance. We have a clear path to profitability and remain committed to building shareholder value,” concluded Mr. Peterson.

Financial Update

For the quarter ending June 30, 2019, the Company generated revenues of approximately $10.37 million, compared to approximately $8.72 million for the second quarter ending June 30, 2018, an increase of approximately $1.65 million or 19%. The increase was primarily due to increased Cannabis revenues due to our Dispensary year-over-year growth of $0.95 million or 14.0% due to increased customer traffic and higher average sale amounts. Also driving the increase is the development of cultivation and production operations, which accounted for $0.58 million of the increase. The Herbs & Produce division increased by $0.12 million year-over-year.

Gross margin for the period ending June 30, 2019 was approximately 47.4% compared to approximately 42.1% for the second quarter ending June 30, 2018. The increase in Gross Margin was primarily due to operational improvements in the cannabis segment.

Selling, general and administrative expenses for the period ending June 30, 2019 were approximately $12.05 million, compared to approximately $9.86 million for the second quarter ending June 30, 2018.

The Company reported a Gain on Interest in Joint Venture of $0.35 million for the period ending June 30, 2019, due to measurement period adjustments recorded for the consolidation of the Nuleaf joint venture.

The net loss attributable to Terra Tech for the period ending June 30, 2019 was approximately $10.14 million or $0.10 per share compared to a loss of approximately $9.97 million or $0.15 per share for the second quarter ending June 30, 2018.

The Company had $1.9 million in cash as of June 30, 2019, compared with $7.2 million as of December 31, 2018.

Stockholders’ equity for the period ending June 30, 2019 amounted to approximately $110.14 million, an increase of approximately $15.27 million compared to approximately $94.87 million as of December 31, 2018.

Business Update

California:

All of Terra Tech’s operating California facilities were issued a provisional license from the State of California, which is valid for one year and requires METRC compliance. The issuance of these licenses ensures that operations will continue in a lawful and uninterrupted manner for the next year.

Santa Ana:

The Company launched its legal cannabis delivery service operating from its state licensed Blüm dispensary in Santa Ana, making Terra Tech a major supplier of medical and adult-use cannabis to Santa Ana and the surrounding cities, such as Irvine, Laguna Beach and Newport Beach. All of the aforementioned cities suffer from a scarcity of existing cannabis dispensaries and launching a premier delivery service enables the Company to expand distribution of its best-in-class cannabis products to reach an even greater number of patients and customers.

Terra Tech has begun the process to fully permit and open a vertically integrated cannabis complex to host large-scale, cannabis-themed events at its East Dyer Road location.

Oakland: The Company is in the final stages of construction at its 13,000 square foot cultivation facility in Hegenberger, Oakland, which is expected to be fully operational upon receipt of State licensing. The Company’s Blüm Oakland dispensary reported strong sales in the second quarter.

San Leandro: Blüm San Leandro commenced sales to the adult use market after receiving City and State approval.

Nevada:

Las Vegas: The Company started the process of opening a CBD only retail location called Blüm CBD in Downtown Las Vegas at its retail location on 121 North 4th Street. The future Blüm CBD is positioned to be easily accessible and draw high volumes of customers on North 4th Street, located just 100 feet from the world-famous Fremont Street Experience which attracts more than 14 million annual visitors. The design of the store is going to be reflective of new Blüm store concepts and the artful vibe of Downtown Las Vegas.

Reno: The Nevada Department of Taxation approved Terra Tech’s agreement to acquire the remainder of the interest in the Blüm Reno dispensary and the building where the facility is located from Forever Green NV and Forever Young Investments, LLC, affiliates of Heidi Loeb Hegerich. Terra Tech Corp.'s ownership in the Blüm dispensary, including its cannabis licenses and the building which houses the dispensary, increased from 50% to 100%.

Conference Call

The company will also host a conference call on Thursday, August 8, 2019 at 4:30 PM Eastern.

Dial-In Number: 1-857-232-0157

Access Code: 422095

Derek Peterson, Chairman and CEO of Terra Tech Corp., will be answering shareholder questions at the end of the call. Should you have questions during or prior to the conference call please send an email [email protected] with TRTC Question in the subject line. Mr. Peterson will answer as many questions as time will allow.

For those unable to participate in the live conference call, a replay will be available at https://www.smallcapvoice.com/trtc/. An archived version of the webcast will also be available on the investor relations section of the company's website.

To be added to the Terra Tech email distribution list, please email [email protected] with TRTC in the subject line.

About Terra Tech

Terra Tech Corp. (OTCQX:TRTC) operates through multiple subsidiary businesses including: Blüm, IVXX Inc., Edible Garden, and MediFarm LLC. Blüm's retail and medical cannabis facilities provide the highest quality medical cannabis to patients who are looking for alternative treatments for their chronic medical conditions as well as premium cannabis to the adult-use market in Nevada and California. Blüm offers a broad selection of cannabis products including; flowers, concentrates and edibles through its multiple California and Nevada locations. IVXX, Inc. is a wholly-owned subsidiary of Terra Tech that produces cannabis-extracted products for regulated cannabis dispensaries throughout California and dispensaries in Nevada. The Company's wholly-owned subsidiary, Edible Garden, cultivates a premier brand of local and sustainably grown hydroponic produce, sold through major grocery stores such as ShopRite, Walmart, Ahold, Aldi, Meijer, Kroger, Stop & Shop and others nationwide. Terra Tech's MediFarm LLC subsidiaries are focused on medical and adult-use cannabis cultivation and permitting businesses throughout Nevada.

For more information about Blüm Retail Stores visit: http://letsblum.com

Visit us on Facebook @ https://www.facebook.com/terratechcorp/timeline

Follow us on Instagram @letsblum

Follow us on Twitter @terratechcorp

For more information about Edible Garden visit: http://www.ediblegarden.com/

Visit Edible Garden on Facebook @ https://www.facebook.com/ediblefarms?fref=ts

Cautionary Language Concerning Forward-Looking Statements

Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Terra Tech Corp. (the "Company") or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed

Revenue increased 19% versus the second quarter in 2018; up 40% from first quarter 2019

IRVINE, CA / ACCESSWIRE / August 8, 2019 / Terra Tech Corp. (OTCQX:TRTC) (“Terra Tech” or the “Company”), a vertically integrated cannabis-focused agriculture company, today announced its financial results for the period ended June 30, 2019.

Derek Peterson, Chief Executive Officer of Terra Tech, commented, “We generated $10.37 million in revenue during the second quarter of 2019, a 19% increase from the $8.72 million in the same period of 2018. Gross margins saw a 526-basis point improvement over the prior year’s quarter due to our lower cost of goods and higher margin private label sales. These strong results were driven by one of our healthiest quarters on the retail level, especially in our San Leandro dispensary which commenced adult use sales in May, further positioning us as a leading vendor in California.

“The Company is as lean and healthy as it has ever been, and future quarterly results are expected to reflect the strength of our retail position and streamlined operations. In addition to our San Leandro performance, this quarter has seen several other milestones, including the launch of Terra Tech’s cannabis delivery service in Santa Ana which has cemented us as a major supplier of medical and adult-use cannabis to Santa Ana and its surrounding cities. The Company has made substantial headway in Nevada as well, where we started the process of opening our Blüm CBD store located in a highly trafficked section of Downtown Las Vegas. In Reno, we acquired complete ownership of our Blüm Reno dispensary allowing us to ramp cultivation and production.

“Our quarterly performance shows that the Company is trending in the right direction. Our restructuring program is well underway and we have already begun transitioning out of our non-core assets, streamlined both our operations and headcount, and identified some potential acquisition targets. Terra Tech is also looking to leverage relationships to investigate operations in the global CBD market due to its wide appeal, opposed to the heavily regulated cannabis market which is yet to see the same level of acceptance. We have a clear path to profitability and remain committed to building shareholder value,” concluded Mr. Peterson.

Financial Update

* For the quarter ending June 30, 2019, the Company generated revenues of approximately $10.37 million, compared to approximately $8.72 million for the second quarter ending June 30, 2018, an increase of approximately $1.65 million or 19%. The increase was primarily due to increased Cannabis revenues due to our Dispensary year-over-year growth of $0.95 million or 14.0% due to increased customer traffic and higher average sale amounts. Also driving the increase is the development of cultivation and production operations, which accounted for $0.58 million of the increase. The Herbs & Produce division increased by $0.12 million year-over-year.

* Gross margin for the period ending June 30, 2019 was approximately 47.4% compared to approximately 42.1% for the second quarter ending June 30, 2018. The increase in Gross Margin was primarily due to operational improvements in the cannabis segment.

* Selling, general and administrative expenses for the period ending June 30, 2019 were approximately $12.05 million, compared to approximately $9.86 million for the second quarter ending June 30, 2018.

* The Company reported a Gain on Interest in Joint Venture of $0.35 million for the period ending June 30, 2019, due to measurement period adjustments recorded for the consolidation of the Nuleaf joint venture.

* The net loss attributable to Terra Tech for the period ending June 30, 2019 was approximately $10.14 million or $0.10 per share compared to a loss of approximately $9.97 million or $0.

Lourdes Felix, CFO, COO and Director of BioCorRx Inc. (OTCQB: BICX) (the “Company”), a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders called in to SmallCapVoice.com, Inc. to talk about the recent launch of the UnCraveRx™ virtual app. UnCraveRx™ is a medically assisted weight loss management program that helps to reduce food cravings combined with on-demand virtual lifestyle support, fitness and nutrition. The UnCraveRx™ App is available now. It is available online www.myuncraverx.com or through the Android or iOS app stores.

BioCorRx Inc. (BICX) is an addiction treatment solutions company offering a unique approach to the treatment of substance use and other related disorders. The BioCorRx® Recovery Program is a non-addictive, medication-assisted treatment (MAT) program for substance use; please visit www.beataddiction.com for more information on the BioCorRx Recovery Program. The UnCraveRx™ Weight Loss Program is also a medication assisted program; please visit www.uncraverx.com for more information on UnCraveRx™. The Company also conducts R&D under its controlled subsidiary, BioCorRx Pharmaceuticals. For more information on BICX and product pipeline, please visit www.BioCorRx.com.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $875 from the company on 7-25-19 for 30 days of service.

Lourdes Felix, CFO, COO and Director of BioCorRx Inc. (OTCQB: BICX) (the “Company”), a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders called in to SmallCapVoice.com, Inc. to talk about the recent launch of the UnCraveRx™ virtual app. UnCraveRx™ is a medically assisted weight loss management program that helps to reduce food cravings combined with on-demand virtual lifestyle support, fitness and nutrition. The UnCraveRx™ App is available now. It is available online www.myuncraverx.com or through the Android or iOS app stores.

BioCorRx Inc. (BICX) is an addiction treatment solutions company offering a unique approach to the treatment of substance use and other related disorders. The BioCorRx® Recovery Program is a non-addictive, medication-assisted treatment (MAT) program for substance use; please visit www.beataddiction.com for more information on the BioCorRx Recovery Program. The UnCraveRx™ Weight Loss Program is also a medication assisted program; please visit www.uncraverx.com for more information on UnCraveRx™. The Company also conducts R&D under its controlled subsidiary, BioCorRx Pharmaceuticals. For more information on BICX and product pipeline, please visit www.BioCorRx.com.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $875 from the company on 7-25-19 for 30 days of service.

Magen McGahee, COO and CFO of Galaxy Next Generation, Inc. (OTCQB: GAXY) (the “Company”) called in to SmallCapVoice.com, Inc. to go over the business model for the Company, the recent milestones for the company in 2019, and the operational goals for the remainder of 2019. Recently, GAXY announced as a result of its recent participation as an exhibitor at GAMEIS (http://www.gameis.org/), in Savannah, GA, it has signed AIOS Group LLC as a value-add reseller.

Galaxy Next Generation (OTCQB: GAXY) is a provider of interactive learning technology solutions that allows the presenter and participant to engage in a fully collaborative instructional environment. Galaxy's products include Galaxy's own private-label interactive touch screen panel as well as numerous other national and international branded peripheral and communication devices. Galaxy's distribution channel consists of 22+ resellers across the U.S. who primarily sell the Company's products within the commercial and educational market. Galaxy does not control where resellers focus their resell efforts, although generally, the K-12 education market is the largest customer base for Galaxy products - comprising nearly 90% of Galaxy's sales.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $3,500 from from a third party on behalf of the issuer on 7-19-19 for 30 days of service.

Magen McGahee, COO and CFO of Galaxy Next Generation, Inc. (OTCQB: GAXY) (the “Company”) called in to SmallCapVoice.com, Inc. to go over the business model for the Company, the recent milestones for the company in 2019, and the operational goals for the remainder of 2019. Recently, GAXY announced as a result of its recent participation as an exhibitor at GAMEIS (http://www.gameis.org/), in Savannah, GA, it has signed AIOS Group LLC as a value-add reseller.

Galaxy Next Generation (OTCQB: GAXY) is a provider of interactive learning technology solutions that allows the presenter and participant to engage in a fully collaborative instructional environment. Galaxy’s products include Galaxy’s own private-label interactive touch screen panel as well as numerous other national and international branded peripheral and communication devices. Galaxy’s distribution channel consists of 22+ resellers across the U.S. who primarily sell the Company’s products within the commercial and educational market. Galaxy does not control where resellers focus their resell efforts, although generally, the K-12 education market is the largest customer base for Galaxy products – comprising nearly 90% of Galaxy’s sales.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $3,500 from from a third party on behalf of the issuer on 7-19-19 for 30 days of service.

S. Parikh Mars, Chief Executive Officer of Progressive Care Inc. (OTC QB: RXMD) called in to SmallCapVoice.com, Inc. to address several topics including what shareholders can expect now with the completion of the acquisition of Family Physicians RX, Inc., dba Five Star RX and Florida corporation (FSRX), what will RXMD be focused on next, how RXMD is able to swiftly adapt to changing and challenging business environment, how company insiders are not involved in daily market activity and more.

Progressive Care Inc. (RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $5,000 from the company on 7/5/19 for 30 days of service.

S. Parikh Mars, Chief Executive Officer of Progressive Care Inc. (OTC QB: RXMD) called in to SmallCapVoice.com, Inc. to address several topics including what shareholders can expect now with the completion of the acquisition of Family Physicians RX, Inc., dba Five Star RX and Florida corporation (FSRX), what will RXMD be focused on next, how RXMD is able to swiftly adapt to changing and challenging business environment, how company insiders are not involved in daily market activity and more.

Progressive Care Inc. (RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $5,000 from the company on 7/5/19 for 30 days of service.

Nightfood CEO Sean Folkson called in to SmallCapVoice.com, Inc. to discuss the big announcement regarding the brand partnership with rock star Michael Clifford, lead guitarist of the multi-platinum, award winning band, 5 Seconds of Summer. As part of the partnership, Nightfood (OTCQB: NGTF) is developing a custom flavor for the chocolate-loving Clifford and how they are already working on a similar custom-flavor deal with another major celebrity. In the interview Folkson talks about the drivers behind the Company's ongoing, highly successful national rollout of its award winning ice cream, the recent news, and much more. Nightfood has now successfully secured distribution in four of the top fifty supermarket chains in the United States within six months of manufacturing their first pint of ice cream. Management is projecting profitability and revenues greater than $3 million in the fourth quarter of 2019.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $875 from the company on 5-31-18 for 30 days of service. SmallCapVoice.com, Inc. received $2,500 from the company on 8-10-18 for 30 days of service. SmallCapVoice.com, Inc. received $2,500 from the company on 9-10-18 for 30 days of service. SmallCapVoice.com, Inc. received $2,500 from the company on 10-10-18 for 30 days of service. Beginning on 11-10-18 will receive $2,500 from the company monthly for 30 days of service on a month to month basis.